Neutrophil membrane potential changes and homotypic aggregation kinetics are pH-dependent: studies of chronic granulomatous disease.
Activated polymorphonuclear neutrophil granulocytes (PMN) from patients with chronic granulomatous disease (CGD) show reduced electron-proton shifts and an inability to acidify the cell. We studied whether this impaired pH-regulating capacity affected PMN membrane potential changes and the kinetics of homotypic aggregation by changing the extracellular pH over a wide range. At pH 7.4 normal PMN showed a rapid, transient membrane depolarization to leukotriene B4 (LTB4) and a slower response to N-formyl-methionyl-leucyl-phenylalanine. In contrast, PMN from 13 patients with CGD exhibited no or minute depolarization to these stimuli and 77% of tested patients with CGD displayed absence or marked reductions of the disaggregation to LTB4. On acidification of pH 5.0 to 6.4, PMN membrane depolarization appeared in six of nine tested patients. Likewise, disaggregation became evident in all of three patients. On alkalinization of normal PMN to pH 8.0 to 9.0, membrane depolarization and disaggregation to LTB4 disappeared, and cells reacted as CGD PMN. This change was not due to inefficient signal transduction, because normal PMN enhanced the superoxide ion production to N-formyl-methionyl-leucyl-phenylalanine on this alkalinization. Cytosolic pH changes in resting and LTB4-activated CGD cells at pH 6.0, 7.4, and 8.5 were similar those in control cells but for absence of an initial acidification. Thus neutrophil membrane potential changes and aggregation kinetics to LTB4 are abnormal in patients with CGD and return toward normal on extracellular acidification.
Ahlin
A
A
Department of Pediatrics, Karolinska Institute, Sachs Children's Hospital, Sweden.
Gyllenhammar
H
H
Ringertz
B
B
Palmblad
J
J
D000293:Adolescent; D000328:Adult; D000838:Anions / Q000378:metabolism; D002449:Cell Aggregation / Q000187:drug effects; D002648:Child; D005260:Female; D006105:Granulomatous Disease, Chronic / Q000503:physiopathology*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D007975:Leukotriene B4 / Q000494:pharmacology; D008163:Luminescent Measurements; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D009580:Nitroblue Tetrazolium; D012016:Reference Values; D013481:Superoxides / Q000378:metabolism
D000838:Anions; D013481:Superoxides; D007975:Leukotriene B4; D009580:Nitroblue Tetrazolium